Virtual Screening in the Identification of Sirtuins' Activity Modulators

Abstract

Sirtuins are NAD⁺-dependent deac(et)ylases with different subcellular localization. The sirtuins' family is composed of seven members, named SIRT-1 to SIRT-7. Their substrates include histones and also an increasing number of different proteins. Sirtuins regulate a wide range of different processes, ranging from transcription to metabolism to genome stability. Thus, their dysregulation has been related to the pathogenesis of different diseases. In this review, we discussed the pharmacological approaches based on sirtuins' modulators (both inhibitors and activators) that have been attempted in in vitro and/or in in vivo experimental settings, to highlight the therapeutic potential of targeting one/more specific sirtuin isoform(s) in cancer, neurodegenerative disorders and type 2 diabetes. Extensive research has already been performed to identify SIRT-1 and -2 modulators, while compounds targeting the other sirtuins have been less studied so far. Beside sections dedicated to each sirtuin, in the present review we also included sections dedicated to pan-sirtuins' and to parasitic sirtuins' modulators. A special focus is dedicated to the sirtuins' modulators identified by the use of virtual screening.

Keywords: activators; cancer; docking; inhibitors; neurodegenerative disease; rational design; sirtuins; type 2 diabetes; virtual screening.

Figure 1

Crystal structures of the 7 human sirtuins. The PDB identifiers for SIRT-1, SIRT-2, SIRT-3, SIRT-5, and SIRT-6 are 4KXQ, 4Y6O, 4BN4, 6LJK, and 6HOY, respectively. SIRT-4 and SIRT-7 do not exist in a crystal structure; thus, the AlphaFold-software-predicted structures are shown with the identifiers AF-A0A347ZJG7-F1 and AF-Q9NRC8-F1, respectively.

Figure 2

Workflow for article selection.